Advertisement
Advertisement
RXST
RxSight, Inc. Common Stock
6.84
USDSponsored
+0.07
+1.00%
Apr 10, 16:00 UTC -4
Closed
After-Market
6.92
+0.08
+1.21%
RXST Earnings Reports
Positive Surprise Ratio
RXST beat 17 of 19 last estimates.
89%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q4 25 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
RxSight, Inc. Common Stock earnings per share and revenue
On Feb 25, 2026, RXST reported earnings of -0.22 USD per share (EPS) for Q4 25, beating the estimate of -0.33 USD, resulting in a 35.10% surprise. Revenue reached 32.61 million, compared to an expected 30.72 million, with a 6.14% difference. The market reacted with a +14.14% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AngioDynamics, Inc.
Report Date
Apr 02, 2026 For Q3 26
Estimate
-$0.11
Actual
$0.02
Surprise
+117.83%
LENSAR, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.07
Actual
-$0.12
Surprise
-68.07%
Xtant Medical Holdings, Inc.
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.00
Actual
$0.00
Surprise
+100.00%
Adagio Medical Holdings, Inc Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$0.31
Actual
-$0.16
Surprise
+49.40%
PAVmed Inc. Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$5.50
Actual
-$5.52
Surprise
-0.22%
American Shared Hospital Services
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.02
Actual
-$0.09
Surprise
-545.54%
NexGel, Inc Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.12
Surprise
-30.72%
ENDRA Life Sciences Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$1.25
Actual
-$3.26
Surprise
-159.84%
FAQ
What were RxSight, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, RxSight, Inc. Common Stock reported EPS of -$0.22, beating estimates by 35.1%, and revenue of $32.61M, 6.14% above expectations.
How did the market react to RxSight, Inc. Common Stock's Q4 2025 earnings?
The stock price moved up 14.14%, changed from $8.84 before the earnings release to $10.09 the day after.
When is RxSight, Inc. Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for RxSight, Inc. Common Stock's next earnings report?
Based on --
analysts, RxSight, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement